Correlation of Platelet-Derived Growth Factor-BB Levels as a Biomarker of Liver Fibrosis with the Degree of Fibrosis Based on Fibroscan in Chronic Hepatitis B Patients

Authors

  • Richard Togi Lumban Tobing Specialized Residency Training, Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Suyata Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  • Mgs. Irsan Saleh Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia

DOI:

https://doi.org/10.37275/bsm.v8i1.913

Keywords:

Fibroscan, Liver fibrosis, PDGF-BB

Abstract

Background: Liver fibrosis is scar tissue that forms due to excessive accumulation of ECM proteins due to chronic liver injury, mediated by cytokines involving complex cellular interactions, such as platelet-derived growth factor-BB (PDGF-BB). In Indonesia, no research has been conducted to determine the correlation between PDGF-BB levels and the degree of liver fibrosis based on fibroscan. The aim of this study is to assess the correlation between PGDF-BB levels and the degree of liver fibrosis based on fibroscan in chronic hepatitis B.

Methods: A cross-sectional study was conducted on the chronic hepatitis B population at the internal medicine clinic of Dr. Mohammad Hoesin General Hospital Palembang from January to Agustus 2023. The assessment uses fibroscan to determine the degree of liver fibrosis, measured in kilopascals (kPa). PDGF-BB levels measured by ELISA.

Results: From 40 subjects, the majority of chronic hepatitis B patients were women (57,5%). The lowest PDGF-BB level was found in chronic hepatitis B patients with fibroscan F0, and the highest PDGF-BB level in fibroscan F4. Fibroscan results are directly proportional to PDGF-BB level.

Conclusion: PDGF-BB has a strong positive correlation with the degree of fibroscan in chronic hepatitis B patients in Dr. Mohammad Hoesin General Hospital. The higher the range of PDGF-BB levels, the higher the degree of fibroscan in chronic hepatitis B patients.

Authors

  • Richard Togi Lumban Tobing1*
  • Suyata2
  • Mgs. Irsan Saleh3
  1. 1Specialized Residency Training, Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  2. 2Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya/Dr. Mohammad Hoesin General Hospital, Palembang, Indonesia
  3. 3Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia

Corresponding author Richard Togi Lumban Tobing — richardtltobing@gmail.com

Article history

  1. Submitted
  2. Accepted
  3. Published

Downloads

Published

2023-12-01

Article metrics

620Abstract views
341PDF downloads

How to Cite

1.
Lumban Tobing RT, Suyata, Mgs. Irsan Saleh. Correlation of Platelet-Derived Growth Factor-BB Levels as a Biomarker of Liver Fibrosis with the Degree of Fibrosis Based on Fibroscan in Chronic Hepatitis B Patients. Bioscmed [Internet]. 2023 Dec. 1 [cited 2026 Aug. 13];8(1):3917-22. Available from: https://bioscmed.com/index.php/bsm/article/view/913

Most read articles by the same author(s)

1 2 > >>